332
Views
3
CrossRef citations to date
0
Altmetric
Review

Treatment of heterozygous familial hypercholesterolemia: what does the future hold?

&
Pages 1229-1234 | Received 14 Sep 2020, Accepted 16 Oct 2020, Published online: 27 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Uffe Ravnskov, Michel de Lorgeril, Malcolm Kendrick & David M. Diamond. (2021) Serious flaws in targeting LDL-C reduction in the management of cardiovascular disease in familial hypercholesterolemia. Expert Review of Clinical Pharmacology 14:3, pages 405-406.
Read now

Articles from other publishers (2)

Lale Tokgozoglu & Meral Kayikcioglu. (2021) Familial Hypercholesterolemia: Global Burden and Approaches. Current Cardiology Reports 23:10.
Crossref
Phuong Dong Tran Nguyen, Nang Hoang Pham & Phuong Kim Truong. (2021) Molecular Characterization of Proprotein Convertase Subtilisin/Kexin Type 9 Gene Mutations in Vietnamese Patients with Hypercholesterolemia. Pharmacophore 12:3, pages 23-28.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.